We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+11.25%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$3.22B
AUM Growth
-$72.5M
Cap. Flow
-$765M
Cap. Flow %
-23.77%
Top 10 Hldgs %
76.64%
Holding
93
New
9
Increased
14
Reduced
27
Closed
16

Top Buys

Rank Stock Value
1
AGN.PRA
Allergan plc
AGN.PRA
+$41.4M
2
IBB icon
iShares Biotechnology ETF
IBB
+$28.7M
3
TWX
Time Warner Inc
TWX
+$15.6M
4
BFH icon
Bread Financial
BFH
+$10.6M
5
CALM icon
Cal-Maine
CALM
+$10.2M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$17.7M
2
MRVL icon
Marvell Technology
MRVL
+$11M
3
TSLA icon
Tesla
TSLA
+$9.56M
4
IMAX icon
IMAX
IMAX
+$7.62M
5
JOYY
JOYY Inc
JOYY
+$7.52M

Sector Composition

Rank Sector Weight
1 Healthcare 55.59%
2 Consumer Discretionary 3.25%
3 Communication Services 2.67%
4 Financials 2.32%
5 Energy 1.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HD icon
26
Home Depot
HD
$332B
$11.3M 0.35%
77,000
– –
RICE
27
DELISTED
Rice Energy Inc.
RICE
$11.2M 0.35%
+473,300
New +$9.82M
GTN icon
28
Gray Television
GTN
$407M
$10.7M 0.33%
737,454
+215,261
+41% +$2.73M
CMBT
29
CMB.TECH NV
CMBT
$4.57B
$10.7M 0.33%
1,350,924
+377,400
+39% +$3.04M
HUNTU
30
DELISTED
Hunter Maritime Acquisition Corp. Unit
HUNTU
$10.4M 0.32%
1,000,000
– –
IOVA icon
31
Iovance Biotherapeutics
IOVA
$2.23B
$10M 0.31%
1,385,309
-113,500
-8% -$832K
JPM icon
32
JPMorgan Chase
JPM
$939B
$9.66M 0.3%
109,985
– –
CALM icon
33
Cal-Maine
CALM
$4.28B
$9.39M 0.29%
+255,100
New +$10.2M
AR icon
34
Antero Resources
AR
$10.9B
$8.52M 0.26%
373,413
– –
WFC icon
35
Wells Fargo
WFC
$261B
$7.89M 0.25%
141,712
– –
XNCR icon
36
Xencor
XNCR
$1.44B
$7.21M 0.22%
301,325
-37,200
-11% -$896K
BLUE
37
DELISTED
bluebird bio
BLUE
$7.18M 0.22%
6,100
-1,244
-17% -$1.27M
ADAP
38
DELISTED
Adaptimmune Therapeutics
ADAP
$6.94M 0.22%
1,360,647
+703,389
+107% +$3.08M
TNK icon
39
Teekay Tankers
TNK
$2.63B
$6.65M 0.21%
405,384
-33,451
-8% -$620K
NAT icon
40
PUT
Nordic American Tanker
NAT
$1.37B
$6.59M 0.2%
812,650
-958,910
-54% -$7.93M
SRPT icon
41
Sarepta Therapeutics
SRPT
$1.66B
$6.56M 0.2%
221,691
+8,915
+4% +$276K
XRT icon
42
State Street SPDR S&P Retail ETF
XRT
$365M
$6.44M 0.2%
152,557
+34,287
+29% +$1.48M
ACAD icon
43
Acadia Pharmaceuticals
ACAD
$4.25B
$6.43M 0.2%
187,055
-57,066
-23% -$2.01M
ICPT
44
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$6.26M 0.19%
55,380
-6,926
-11% -$809K
ONC
45
BeOne Medicines Ltd
ONC
$33.8B
$6.22M 0.19%
170,000
– –
EPZM
46
DELISTED
Epizyme, Inc
EPZM
$6.1M 0.19%
355,445
-174,836
-33% -$2.33M
TSRO
47
DELISTED
TESARO, Inc.
TSRO
$5.57M 0.17%
36,179
-10,952
-23% -$1.78M
DHT icon
48
DHT Holdings
DHT
$2.97B
$5.39M 0.17%
1,206,051
+134,085
+13% +$622K
BMRN icon
49
BioMarin Pharmaceuticals
BMRN
$11.5B
$5.14M 0.16%
58,517
-4,662
-7% -$415K
ARWR icon
50
Arrowhead Research
ARWR
$12.1B
$4.73M 0.15%
2,556,256
– –
1
2
3 4

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

QVT Financial's Q1 2017 Portfolio in Review

As of Q1 2017, QVT Financial held 93 positions worth $3.22B, down 2.2% from $3.29B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

QVT Financial withdrew a net $765M in Q1 2017, closing 16 positions and reducing 27 holdings. Its most notable exit was Marvell Technology, an estimated $11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 49% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, QVT Financial opened a new position in Allergan plc worth $42.4M.

  • QVT Financial's largest Q1 2017 buy was Allergan plc: 50,000 shares worth $42.4M.
  • QVT Financial added most to iShares Biotechnology ETF in Q1 2017, an estimated $28.7M increase.
  • QVT Financial's biggest Q1 2017 reduction was Intel, cutting an estimated $17.7M.
  • QVT Financial fully exited Marvell Technology in Q1 2017, selling an estimated $11M.
  • QVT Financial's ten largest holdings make up 77% of its $3.22B portfolio in Q1 2017.
  • QVT Financial opened 9 new positions and closed 16 in Q1 2017.
  • QVT Financial's portfolio value fell 2.2% quarter-over-quarter to $3.22B.

Based on QVT Financial's 13F filing for Q1 2017, filed 15 May 2017.